BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chattopadhyay K. A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet 2011;17:132-44. [PMID: 22345983 DOI: 10.4103/0971-6866.92087] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Shen J, Zhou H, Liu J, Zhang Z, Fang W, Yang Y, Hong S, Xian W, Ma Y, Zhou T, Zhang Y, Zhao H, Huang Y, Zhang L. Incidence and risk factors of second primary cancer after the initial primary human papillomavirus related neoplasms. MedComm (2020) 2020;1:400-9. [PMID: 34766131 DOI: 10.1002/mco2.43] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Rotimi SO, Rotimi OA, Salhia B. A Review of Cancer Genetics and Genomics Studies in Africa. Front Oncol 2020;10:606400. [PMID: 33659210 DOI: 10.3389/fonc.2020.606400] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
3 Merchant R, Doctor P, Varaiya A. Molecular basis of susceptibility and protection from microbial infections. Clinical Molecular Medicine 2020. [DOI: 10.1016/b978-0-12-809356-6.00023-x] [Reference Citation Analysis]
4 Gensterblum-Miller E, Brenner JC. Protecting Tumors by Preventing Human Papilloma Virus Antigen Presentation: Insights from Emerging Bioinformatics Algorithms. Cancers (Basel) 2019;11:E1543. [PMID: 31614809 DOI: 10.3390/cancers11101543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Chambuso R, Ramesar R, Kaambo E, Denny L, Passmore JA, Williamson AL, Gray CM. Human Leukocyte Antigen (HLA) Class II -DRB1 and -DQB1 Alleles and the Association with Cervical Cancer in HIV/HPV Co-Infected Women in South Africa. J Cancer 2019;10:2145-52. [PMID: 31258717 DOI: 10.7150/jca.25600] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
6 Blomberg M, Dehlendorff C, Kjaer SK. Risk of CIN2+ following a diagnosis of genital warts: a nationwide cohort study. Sex Transm Infect 2019;95:614-8. [PMID: 31092605 DOI: 10.1136/sextrans-2019-054008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gheit T. Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology. Front Oncol 2019;9:355. [PMID: 31134154 DOI: 10.3389/fonc.2019.00355] [Cited by in Crossref: 96] [Cited by in F6Publishing: 98] [Article Influence: 32.0] [Reference Citation Analysis]
8 Chauhan A, Pandey N, Raithatha N, Patel P, Desai A, Jain N. Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer. F1000Res 2018;7:606. [PMID: 30345020 DOI: 10.12688/f1000research.14840.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Adebamowo SN, Dareng EO, Famooto AO, Offiong R, Olaniyan O, Obende K, Adebayo A, Ologun S, Alabi B, Achara P, Bakare RA, Odutola M, Olawande O, Okuma J, Odonye G, Adebiyi R, Dakum P, Adebamowo CA; ACCME Research Group as part of the H3Africa Consortium. Cohort Profile: African Collaborative Center for Microbiome and Genomics Research's (ACCME's) Human Papillomavirus (HPV) and Cervical Cancer Study. Int J Epidemiol 2017;46:1745-1745j. [PMID: 28419249 DOI: 10.1093/ije/dyx050] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
10 Chauhan A, Pandey N, Raithatha N, Patel P, Desai A, Jain N. Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer. F1000Res 2018;7:606. [DOI: 10.12688/f1000research.14840.1] [Reference Citation Analysis]
11 Chotipanich A, Siriarechakul S, Mungkung OO. Role of high-risk human papillomavirus in the etiology of oral and oropharyngeal cancers in Thailand: A case-control study. SAGE Open Med 2018;6:2050312118765604. [PMID: 29623202 DOI: 10.1177/2050312118765604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Daniel M, Cătană A, Popp RA, Dumitraș DE, Stamatian F, Buzoianu AD, Rotar IC. Genetic polymorphisms of glutathione S transferase and cervical intraepithelial neoplasia. Revista Romana de Medicina de Laborator 2016;24:377-86. [DOI: 10.1515/rrlm-2016-0036] [Reference Citation Analysis]
13 Del Río-Ospina L, Soto-De León SC, Camargo M, Sánchez R, Mancilla CL, Patarroyo ME, Patarroyo MA. The Prevalence of High-Risk HPV Types and Factors Determining Infection in Female Colombian Adolescents. PLoS One 2016;11:e0166502. [PMID: 27846258 DOI: 10.1371/journal.pone.0166502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
14 Khosravi P, Gazestani VH, Pirhaji L, Law B, Sadeghi M, Goliaei B, Bader GD. Inferring interaction type in gene regulatory networks using co-expression data. Algorithms Mol Biol 2015;10. [DOI: 10.1186/s13015-015-0054-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
15 Mählmann K, Hamza E, Marti E, Dolf G, Klukowska J, Gerber V, Koch C. Increased FOXP3 expression in tumour-associated tissues of horses affected with equine sarcoid disease. The Veterinary Journal 2014;202:516-21. [DOI: 10.1016/j.tvjl.2014.09.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
16 Gimenes F, Teixeira JJ, de Abreu AL, Souza RP, Pereira MW, da Silva VR, Bôer CG, Maria-Engler SS, Bonini MG, Borelli SD, Consolaro ME. Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: a candidate molecule for therapeutic intervention and prognostic biomarker? Biochim Biophys Acta 2014;1846:576-89. [PMID: 25453366 DOI: 10.1016/j.bbcan.2014.10.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
17 Tabatabai MA, Kengwoung-Keumo JJ, Eby WM, Bae S, Guemmegne JT, Manne U, Fouad M, Partridge EE, Singh KP. Disparities in cervical cancer mortality rates as determined by the longitudinal hyperbolastic mixed-effects type II model. PLoS One 2014;9:e107242. [PMID: 25226583 DOI: 10.1371/journal.pone.0107242] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
18 Banister CE, Messersmith AR, Cai B, Spiryda LB, Glover SH, Pirisi L, Creek KE. Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age. J Infect Dis 2015;211:100-8. [PMID: 25028692 DOI: 10.1093/infdis/jiu394] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
19 González-herrera L, Rodríguez-morales P, del Refugio González-losa M, Pérez-mendoza G, Canul-canché J, Rosado-lópez I, de Cetina TC. MTHFR/p53 Polymorphisms as Genetic Factors for Cervical Intraepithelial Neoplasia and Cervical Cancer in HPV-infected Mexican Women. Int J Biol Markers 2014;29:142-9. [DOI: 10.5301/jbm.5000070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
20 Marinho-Dias J, Ribeiro J, Monteiro P, Loureiro J, Baldaque I, Medeiros R, Sousa H. Characterization of cytomegalovirus and epstein-barr virus infection in cervical lesions in Portugal. J Med Virol 2013;85:1409-13. [PMID: 23765777 DOI: 10.1002/jmv.23596] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
21 Metcalfe S, Roger M, Faucher MC, Coutlée F, Franco EL, Brassard P. The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec. Hum Immunol 2013;74:1610-5. [PMID: 23994586 DOI: 10.1016/j.humimm.2013.08.279] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
22 Metcalfe S, Roger M, Faucher MC, Coutlée F, Franco EL, Brassard P. The frequency of HLA alleles in a population of Inuit women of northern Quebec. Int J Circumpolar Health 2013;72. [PMID: 23986892 DOI: 10.3402/ijch.v72i0.21350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
23 Schabath MB, Villa LL, Lin HY, Fulp WJ, Akogbe GO, Abrahamsen ME, Papenfuss MR, Lazcano-Ponce E, Salmerón J, Quiterio M, Giuliano AR. Racial differences in the incidence and clearance of human papilloma virus (HPV): the HPV in men (HIM) study. Cancer Epidemiol Biomarkers Prev 2013;22:1762-70. [PMID: 23872745 DOI: 10.1158/1055-9965.EPI-13-0303] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
24 Marangon AV, Guelsin GA, Visentainer JE, Borelli SD, Watanabe MA, Consolaro ME, Caleffi-Ferracioli KR, Rudnick CC, Sell AM. The association of the immune response genes to human papillomavirus-related cervical disease in a Brazilian population. Biomed Res Int 2013;2013:146079. [PMID: 23936772 DOI: 10.1155/2013/146079] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]